Udayavni Special

Zydus Cadila seeks DCGI nod for human clinical trials of antibodies cocktail to treat COVID-19


PTI, May 27, 2021, 11:36 AM IST

Credit: Reuters Photo

New Delhi: Zydus Cadila on Thursday said it is seeking permission from Drugs Controller General of India (DCGI) to initiate human clinical trials for monoclonal antibodies cocktail for treatment of COVID-19.

“Zydus is currently seeking permission to initiate phase 1/3 human clinical trials from the DCGI… ZRC-3308, a cocktail of two SARS-CoV-2-neutralizing monoclonal antibodies (mAbs) can emerge as one of the main treatments for mild COVID 19,” Cadila Healthcare said in a regulatory filing.

Cadila Healthcare is the listed entity of the group.

ZRC-3308 has been found to be safe and well tolerated in animal toxicology studies.

Zydus said it is the only Indian company to have developed a neutralizing monoclonal antibody based cocktail for the treatment of COVID-19.

Dr Sharvil Patel, Managing Director, Cadila Healthcare Ltd said, “At this juncture, there is a critical need to explore safer and more efficacious treatments to combat COVID. It is important to look at different stages of the disease progression and look at options that can reduce patient’s suffering and discomfort.

“We believe that ZRC-3308 has the potential to address these concerns and provide a safe treatment.”

Earlier this week, drug majors Roche India and Cipla announced the launch of Roche’s Antibody Cocktail in India priced at Rs 59,750 per dose for the treatment of mild to moderate COVID-19 in patients who are at high risk.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Delhi riots: Court defers order on ‘immediate release’ of student activists for Thursday

British PM forced to defend India travel ban timing over Delta variant in Parliament

Ambani bomb scare case: NIA seeks custody of former cop

COVID: At least half of judges should sit on alternate days to hear those in distress, says SC

No question of leadership change: Nalin Kumar Kateel

‘Two great powers’: 1st round of talks ends at Biden-Putin summit

Cong to undertake campaign to help Covid pandemic-affected people, gather data on deceased



MUST WATCH

Udayavani 16-JUN-2021 News Bulletin

100 % sure that I was targeted in drugs case, says Ragini Dwivedi

Baby Elephant Operates Hand Pump on Its Own to Drink Water

Suresh Shetty Gulme | Success Story of Modern Cow Dairy Farming | Kannada

Complete Guide on Mango Farming | Harvesting Techniques

Latest Additions

Delhi riots: Court defers order on ‘immediate release’ of student activists for Thursday

British PM forced to defend India travel ban timing over Delta variant in Parliament

Ambani bomb scare case: NIA seeks custody of former cop

COVID: At least half of judges should sit on alternate days to hear those in distress, says SC

No question of leadership change: Nalin Kumar Kateel

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.